Psycholinguistics of aphasia pharmacotherapy: Asking the right questions

REFERENCES

• Aarsland, D., Larsen, J. P., Reinvang, I., & Aasland, A. M. (1994). Effects of cholinergic blockade on language in healthy young women: Implications for the cholinergic hypothesis in dementia of the Alzheimer type. Brain, 117(6), 1377–1384. doi:10.1093/brain/117.6.1377
   PubMed Web of Science ®Google Scholar
• Albert, M. L. (1988). Neurobiological aspects of aphasia therapy. Aphasiology, 2(3–4), 215–218. doi:10.1080/02687038808248912
   Google Scholar
• Albert, M. L. (2000). Toward a neurochemistry of naming and anomia. In Y. Grodzinsky, L. Shapiro, & D. Swinney (Eds.), Language and the brain (pp. 157–165). San Diego, CA: Academic Press.
   Google Scholar
• Alexander, M. P. (2006). Impairments of procedures for implementing complex language are due to disruption of frontal attention processes. Journal of the International Neuropsychological Society: JINS, 12(2), 236–247. doi:10.1017/S1355617706060309
   Google Scholar
• Angwin, A. J., Copland, D. A., Chenery, H. J., Murdoch, B. E., & Silburn, P. A. (2006). The influence of dopamine on semantic activation in Parkinson’s disease. Neuropsychology, 20, 299–306.
   PubMed Web of Science ®Google Scholar
• Arciniegas, D. B., Frey, K. L., Anderson, C. A., Brousseau, K. M., & Harris, S. N. (2004). Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Injury, 18(12), 1309–1318.
   PubMed Web of Science ®Google Scholar
• Ashtary, F., Janghorbani, M., Chitsaz, A., Reisi, M., & Bahrami, A. (2006). A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology, 66(6), 914–916. doi:10.1212/01.wnl.0000203119.91762.0c
   PubMed Web of Science ®Google Scholar
• Barrett, A. M., & Eslinger, P. J. (2007). Amantadine for adynamic speech: Possible benefit for aphasia? American Journal of Physical Medicine and Rehabilitation, 86(8), 605–612.
   PubMed Web of Science ®Google Scholar
• Benton, A. L., & Hamsher, K. (1976). Multilingual aphasia examination. Iowa: University of Iowa.
   Google Scholar
• Berthier, M.L. (1999). Transcortical aphasia. Hove: Psychology Press.
   Google Scholar
• Berthier, M. L. (2005). Poststroke aphasia: Epidemiology, pathophysiology and treatment. Drugs & Aging, 22(2), 163–182.
   PubMed Web of Science ®Google Scholar
• Berthier, M. L., García-Casares, N., Walsh, S. F., Nabrozidis, A., de Mier, R. J. R., Green, C., … Pulvermüller, F. (2011). Recovery from post-stroke aphasia: Lessons from brain imaging and implications for rehabilitation and biological treatments. Discovery Medicine, 12(65), 275–289.
   PubMed Web of Science ®Google Scholar
• Berthier, M. L., Green, C., Higueras, C., Fernández, I., Hinojosa, J., & Martín, M. C. (2006). A randomized, placebo-controlled study of donepezil in poststroke aphasia. Neurology, 67(9), 1687–1689. doi:10.1212/01.wnl.0000242626.69666.e2
   PubMed Web of Science ®Google Scholar
• Berthier, M. L., Green, C., Lara, J. P., Higueras, C., Barbancho, M. A., Dávila, G., & Pulvermüller, F. (2009). Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Annals of Neurology, 65(5), 577–585. doi:10.1002/ana.21597
   PubMed Web of Science ®Google Scholar
• Berthier, M. L., Hinojosa, J., Martín, M. del C., & Fernández, I. (2003). Open-label study of donepezil in chronic poststroke aphasia. Neurology, 60(7), 1218–1219. doi:10.1212/01.WNL.0000055871.82308.41
   PubMed Web of Science ®Google Scholar
• Berthier, M. L., Hinojosa, J., & Moreno-Torre, I. (2004). Beneficial effects of donepezil and modality-specific language therapy on chronic conduction aphasia. Neurology, 62(Suppl 5), A462.
   Google Scholar
• Berthier, M. L., & Pulvermüller, F. (2011). Neuroscience insights improve neurorehabilitation of poststroke aphasia. Nature Reviews Neurology, 7(2), 86–97. doi:10.1038/nrneurol.2010.201
   PubMed Web of Science ®Google Scholar
• Beversdorf, D. Q., Narayanan, A., Hillier, A., & Hughes, J. D. (2007). Network model of decreased context utilization in autism spectrum disorder. Journal of Autism and Developmental Disorders, 37(6), 1040–1048. doi:10.1007/s10803-006-0242-7
   PubMed Web of Science ®Google Scholar
• Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G. L. (2000). Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 21(1), 19–22.
   PubMed Web of Science ®Google Scholar
• Breitenstein, C., Wailke, S., Bushuven, S., Kamping, S., Zwitserlood, P., Ringelstein, E. B., & Knecht, S. (2004). D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 29(9), 1704–1714. doi:10.1038/sj.npp.1300464
   PubMed Web of Science ®Google Scholar
• Cahana-Amitay, D., Albert, M. L., Pyun, S.-B., Westwood, A., Jenkins, T., Wolford, S., & Finley, M. (2011). Language as a stressor in aphasia. Aphasiology, 25(2), 593–614. doi:10.1080/02687038.2010.541469
   PubMed Web of Science ®Google Scholar
• Caplan, D. (2009). Experimental design and interpretation of functional neuroimaging studies of cognitive processes. Human Brain Mapping, 30(1), 59–77. doi:10.1002/hbm.20489
   PubMed Web of Science ®Google Scholar
• Chen, Y., Li, Y.-S., Wang, Z.-Y., Xu, Q., Shi, G.-W., & Lin, Y. (2010). The efficacy of donepezil for post-stroke aphasia: A pilot case control study. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine], 49(2), 115–118.
   PubMedGoogle Scholar
• Cherney, L. R., Erickson, R. K., & Small, S. L. (2010). Epidural cortical stimulation as adjunctive treatment for non-fluent aphasia: Preliminary findings. Journal of Neurology, Neurosurgery, and Psychiatry, 81(9), 1014–1021. doi:10.1136/jnnp.2009.184036
   PubMed Web of Science ®Google Scholar
• Cohen, L., Chaaban, B., & Habert, M. O. (2004). Transient improvement of aphasia with zolpidem. New England Journal of Medicine, 350(9), 949–950.
   PubMed Web of Science ®Google Scholar
• Connor, L. T., & Fucetola, R. P. (2011). Assessment of attention in people with aphasia: Challenges and recommendations. Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, 21(2), 55–63. doi:10.1044/nnsld21.2.55
   Google Scholar
• Corbett, F., Jefferies, E., & Lambon Ralph, M. A. (2008). The use of cueing to alleviate recurrent verbal perseverations: Evidence from transcortical sensory aphasia. Aphasiology, 22(4), 363–382. doi:10.1080/02687030701415245
   Web of Science ®Google Scholar
• Crosson, B., Moore, A. B., Gopinath, K., White, K. D., Wierenga, C. E., Gaiefsky, M. E., … Gonzalez Rothi, L. J. (2005). Role of the right and left hemispheres in recovery of function during treatment of intention in aphasia. Journal of Cognitive Neuroscience, 17(3), 392–406. doi:10.1162/0898929053279487
   PubMed Web of Science ®Google Scholar
• Darley, F. L., Keith, R. L., & Sasanuma, S. 1977. The effect of alerting and tranquilizing drugs on upon the performance of aphasic patients. Clinical Aphasiology, 7, 91–96.
   Google Scholar
• De Boissezon, X., Peran, P., De Boysson, C., & Démonet, J.-F. (2007). Pharmacotherapy of aphasia: Myth or reality? Brain and Language, 102(1), 114–125. doi:10.1016/j.bandl.2006.07.004
   PubMed Web of Science ®Google Scholar
• Floel, A., & Cohen, L. G. (2010). Recovery of function in humans: Cortical stimulation and pharmacological treatments after stroke. Neurobiology of Disease, 37(2), 243–251. doi:10.1016/j.nbd.2009.05.027
   PubMed Web of Science ®Google Scholar
• Gold, M., Van Dam, D., & Silliman, E. R. (2000). An open-label trial of bromocriptine in nonfluent aphasia: A qualitative analysis of word storage and retrieval. Brain and Language, 74(2), 141–156.
   PubMed Web of Science ®Google Scholar
• Goral, M., Clark-Cotton, M., Spiro, A., Obler, L. K., Verkuilen, J., & Albert, M. L. (2011). The contribution of set switching and working memory to sentence processing in older adults. Experimental Aging Research, 37(5), 516–538. doi:10.1080/0361073X.2011.619858
   PubMed Web of Science ®Google Scholar
• Gotts, S. J., Della Rocchetta, A. I., & Cipolotti, L. (2002). Mechanisms underlying perseveration in aphasia: Evidence from a single case study. Neuropsychologia, 40(12), 1930–1947. doi:10.1016/S0028-3932(02)00067-2
   PubMed Web of Science ®Google Scholar
• Güngör, L., Terzi, M., & Onar, M. K. (2011). Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases? Brain and Language, 117(1), 23–27. doi:10.1016/j.bandl.2010.11.003
   PubMed Web of Science ®Google Scholar
• Gupta, S. R., & Mlcoch, A. G. (1992). Bromocriptine treatment of nonfluent aphasia. Archives of Physical Medicine and Rehabilitation, 73(4), 373–376.
   PubMed Web of Science ®Google Scholar
• Gupta, S. R., Mlcoch, A. G., Scolaro, C., & Moritz, T. (1995). Bromocriptine treatment of nonfluent aphasia. Neurology, 45, 2170–2173.
   PubMed Web of Science ®Google Scholar
• Hasselmo, M. E., Linster, C., Patil, M., Ma, D., & Cekic, M. (1997). Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. Journal of Neurophysiology, 77(6), 3326–3339.
   PubMed Web of Science ®Google Scholar
• Heilman, K. M., Nadeau, S. E., & Beversdorf, D. O. (2003). Creative innovation: Possible brain mechanisms. Neurocase, 9(5), 369–379. doi:10.1076/neur.9.5.369.16553
   PubMed Web of Science ®Google Scholar
• Heiss, W.-D., & Thiel, A. (2006). A proposed regional hierarchy in recovery of post-stroke aphasia. Brain and Language, 98(1), 118–123. doi:10.1016/j.bandl.2006.02.002
   PubMed Web of Science ®Google Scholar
• Hong, J. M., Shin, D. H., Lim, T. S., Lee, J. S., & Huh, K. (2012). Galantamine administration in chronic post-stroke aphasia. Journal of Neurology, Neurosurgery, and Psychiatry, 83, 675–680. doi: 10.1136/jnnp-2012-302268
   PubMed Web of Science ®Google Scholar
• Huber, W., Willmes, K., Poeck, K., Van Vleymen, B., & Deberdt, W. (1997). Piracetam as an adjuvant to language therapy for aphasia: A randomized double-blind placebo-controlled pilot study. Archives of Physical Medicine and Rehabilitation, 78(3), 245–250.
   PubMed Web of Science ®Google Scholar
• Jianu, D. C., Muresanu, D. F., Bajenaru, O., Popescu, B. O., Deme, S. M., Moessler, H., … Ursoniu, S. (2010). Cerebrolysin adjuvant treatment in Broca’s aphasics following first acute ischemic stroke of the left middle cerebral artery. Journal of Medicine and Life, 3(3), 297–307.
   PubMedGoogle Scholar
• Johnson, N. A., Rademaker, A., Weintraub, S., Gitelman, D., Wienecke, C., & Mesulam, M. (2010). Pilot trial of memantine in primary progressive aphasia. Alzheimer Disease and Associated Disorders, 24(3), 308.
   PubMed Web of Science ®Google Scholar
• Kaplan, E. (1983). Boston naming test. Philadelphia, PA: Lea & Febiger.
   Google Scholar
• Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., & Brashear, R. 2008. Galantamine in frontotemporal dementia and primary progressive aphasia. Dementia and Geriatric Cognitive Disorders, 25, 178–185.
   PubMed Web of Science ®Google Scholar
• Kertesz, A., Sheppard, A., & MacKenzie, R. (1982). Localization in transcortical sensory aphasia. Archives of Neurology, 39(8), 475–478.
   PubMed Web of Science ®Google Scholar
• Kessler, J., Thiel, A., Karbe, H., & Heiss, W. D. (2000). Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke; A Journal of Cerebral Circulation, 31(9), 2112–2116.
   PubMed Web of Science ®Google Scholar
• Kiran, S., & Johnson, L. (2008). Semantic complexity in treatment of naming deficits in aphasia: Evidence from well-defined categories. American Journal of Speech-Language Pathology, 17(4), 389–400. doi:10.1044/1058–0360(2008/06–0085
   PubMed Web of Science ®Google Scholar
• Kiran, S., & Thompson, C. K. (2003). The role of semantic complexity in treatment of naming deficits: Training semantic categories in fluent aphasia by controlling exemplar typicality. Journal of Speech, Language, and Hearing Research, 46(4), 773–787. doi:10.1044/1092-4388(2003/061
   PubMed Web of Science ®Google Scholar
• Klein, R. B., & Albert, M. L. (2004). Can drug therapies improve language functions of individuals with aphasia? A review of the evidence. Seminars in Speech and Language, 25(2), 193–204. doi:10.1055/s-2004-825655
   PubMedGoogle Scholar
• Knecht, S., Breitenstein, C., Bushuven, S., Wailke, S., Kamping, S., Flöel, A., … Ringelstein, E. B. (2004). Levodopa: Faster and better word learning in normal humans. Annals of Neurology, 56(1), 20–26. doi:10.1002/ana.20125
   PubMed Web of Science ®Google Scholar
• Kurland, J. (2011). The role that attention plays in language processing. Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, 21(2), 47–54.
   Google Scholar
• Laska, A. C., von Arbin, M., Kahan, T., Hellblom, A., & Murray, V. (2005). Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: A randomised, double-blind, placebo-controlled study. Cerebrovascular Diseases, 19(2), 125–132.
   PubMed Web of Science ®Google Scholar
• Lazar, R. M., & Antoniello, D. (2008). Variability in recovery from aphasia. Current Neurology and Neuroscience Reports, 8(6), 497–502.
   PubMed Web of Science ®Google Scholar
• Lee, A. W., & Hillis, A. E. (2008). The pharmacological treatment of aphasia. In B. Stemmer & H. A. Whitaker (Eds.), Handbook of the neuroscience of language (pp. 407–415). London: Academic Press.
   Google Scholar
• Leeman, B., Laganaro, M., Chetelat-Mabillard, D., & Schnider, A. (2011). Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo. Neurorehabilition and Neural Repair, 25(1), 43–47.
   PubMed Web of Science ®Google Scholar
• Luriiâ, A. R. (1970). Traumatic aphasia: Its syndromes, psychology and treatment. The Hague: Mouton.
   Google Scholar
• MacLennan, D. L., Nicholas, L. E., Morley, G. K., & Brookshire, R. H. (1991). The effects of bromocriptine on speech and language function in a man with transcortical aphasia. Clinical Aphasiology, 21, 145–155.
   Google Scholar
• Martin, N., & Reilly, J. J. (2012). Introduction to special issue. Short-term memory/working memory impairments in aphasia: Data, models and their application to aphasia rehabilitation. Aphasiology, 26(3/4), 253–257.
   Web of Science ®Google Scholar
• McNamara, P., & Albert, M. L. (2004). Neuropharmacology of verbal perseveration. Seminars in Speech and Language, 25(4), 309–321. doi:10.1055/s-2004-837244
   PubMedGoogle Scholar
• McNeil, M. R., Doyle, P. J., Spencer, K. A., Goda, A. J., Flores, D., & Small, S. L. (1997). A double-blind, placebo-controlled study of pharmacological and behavioural treatment of lexical-semantic deficits in aphasia. Aphasiology, 11(4–5), 385–400.
   Web of Science ®Google Scholar
• McNeil, M. R., Small, S. L., Masterson, R. J., & Fossett, T. R. D. (1995). Behavioral and pharmacological treatment of lexical-semantic deficits in a single patient with primary progressive aphasia. American Journal of Speech-Language Pathology, 4(4), 76–87.
   Google Scholar
• Mimura, M., Albert, M. L., & McNamara, P. (1995). Toward a pharmacotherapy for aphasia. In H. Kirshner (Ed.), Handbook of neurological speech and language disorders (pp. 465–482). New York, NY: Marcel Dekker.
   Google Scholar
• Nadeau, S. E., & Wu, S. S. (2006). CIMT as a behavioral engine in research on physiological adjuvants to neurorehabilitation: The challenge of merging animal and human research. NeuroRehabilitation, 21(2), 107–130.
   PubMed Web of Science ®Google Scholar
• Obler, L. K., & Albert, M. L. (1979). The action naming test (experimental edition). Boston, MA: VA Medical Center.
   Google Scholar
• Orgogozo, J. M. (1999). Piracetam in the treatment of acute stroke. Pharmacopsychiatry, 32(Suppl. 1), 25–32.
   PubMed Web of Science ®Google Scholar
• Ozeren, A., Sarica, Y., Mavi, H., & Demirkiran, M. (1995). Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia. Acta Neurologica Belgica, 95(4), 235–238.
   PubMed Web of Science ®Google Scholar
• Pashek, G. V., & Bachman, D. L. (2003). Cognitive, linguistic, and motor speech effects of donepezil hydrochloride in a patient with stroke-related aphasia and apraxia of speech. Brain and Language, 87, 179–180.
   Web of Science ®Google Scholar
• Pulvermüller, F., Neininger, B., Elbert, T., Mohr, B., Rockstroh, B., Koebbel, P., & Taub, E. (2001). Constraint-induced therapy of chronic aphasia after stroke. Stroke; A Journal of Cerebral Circulation, 32(7), 1621–1626.
   PubMed Web of Science ®Google Scholar
• Rapp, B., Caplan, D., Edwards, S., Visch-Brink, E., & Thompson, C. K. (2013). Neuroimaging in aphasia treatment research: Issues of experimental design for relating cognitive to neural changes. NeuroImage, 73, 200–207. doi:10.1016/j.neuroimage.2012.09.007
   Google Scholar
• Rapp, B., & Goldrick, M. (2006). Speaking words: Contributions of cognitive neuropsychological research. Cognitive Neuropsychology, 23(1), 39–73. doi:10.1080/02643290542000049
   PubMed Web of Science ®Google Scholar
• Raymer, A. M. (2003). Treatment of adynamia in aphasia. Frontiers in Bioscience: A Journal and Virtual Library, 8, s845–s851.
   PubMed Web of Science ®Google Scholar
• Raymer, A. M., Bandy, D., Adair, J. C., Schwartz, R. L., Williamson, D. J., Gonzalez Rothi, L. J., & Heilman, K. M. (2001). Effects of bromocriptine in a patient with crossed nonfluent aphasia: A case report. Archives of Physical Medicine and Rehabilitation, 82(1), 139–144. doi:10.1053/apmr.2001.18056
   PubMed Web of Science ®Google Scholar
• Reed, D. A., Johnson, N. A., Thompson, C., Weintraub, S., & Mesulam, M. M. (2004). A clinical trial of bromocriptine for treatment of primary progressive aphasia. Annals of Neurology, 56(5), 750. doi: 10.1002/ana.20301
   PubMed Web of Science ®Google Scholar
• Sabe, L., Leiguarda, R., & Starkstein, S. E. (1992). An open-label trial of bromocriptine in nonfluent aphasia. Neurology, 42, 1637–1638.
   PubMed Web of Science ®Google Scholar
• Sabe, L., Salvarezza, F., García Cuerva, A., Leiguarda, R., & Starkstein, S. (1995). A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology, 45(12), 2272–2274.
   PubMed Web of Science ®Google Scholar
• Sarter, M., Hasselmo, M. E., Bruno, J. P., & Givens, B. (2005). Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection. Brain Research Brain Research Reviews, 48(1), 98–111. doi:10.1016/j.brainresrev.2004.08.006
   PubMed Web of Science ®Google Scholar
• Seniów, J., Litwin, M., Litwin, T., Leśniak, M., & Członkowska, A. (2009). New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. Journal of the Neurological Sciences, 283(1–2), 214–218. doi:10.1016/j.jns.2009.02.336
   PubMed Web of Science ®Google Scholar
• Shisler, R. J., Baylis, G. C., & Frank, E. M. (2000). Pharmacological approaches to the treatment and prevention of aphasia. Aphasiology, 14(12), 1163–1186. doi:10.1080/02687030050205705
   Web of Science ®Google Scholar
• Small, S. L. (1994). Pharmacotherapy of aphasia. A critical review. Stroke, 25(6), 1282–1289. doi:10.1161/01.STR.25.6.1282
   PubMed Web of Science ®Google Scholar
• Small, S. L. (2000). The future of aphasia treatment. Brain and Language, 71(1), 227–232. doi:10.1006/brln.1999.2256S
   PubMedGoogle Scholar
• Small, S. L., & Llano, D. A. (2009). Biological approaches to aphasia treatment. Current Neurology and Neuroscience Reports, 9(6), 443–450. doi:10.1007/s11910-009-0066-x
   PubMed Web of Science ®Google Scholar
• Sommer, I. E. C., Oranje, B., Ramsey, N. F., Klerk, F. A., Mandl, R. C. W., Westenberg, H. G. M., & Kahn, R. S. (2006). The influence of amphetamine on language activation: An fMRI study. Psychopharmacology, 183(4), 387–393. doi:10.1007/s00213-005-0176-3
   PubMed Web of Science ®Google Scholar
• Tanaka, Y., & Albert, M. L. (2001). Cholinergic therapy for fluent aphasia. Presented at the Annual Meeting of American Neurological Association, Chicago, IL.
   Google Scholar
• Tanaka, Y., Albert, M. L., Aketa, S., Hujita, K., Noda, E., Takashima, M., … Tanaka, M. (2004). Serotonergic therapy for fluent aphasia. Neurology, 62(7, Suppl. S5), A166.
   Web of Science ®Google Scholar
• Tanaka, Y., Albert, M. L., Fujita, K., Nonaka, C., & Oka, T. (2007). Beta blocker improves language output in aphasia. Neurological Medicine (Japan), 67, 277–281.
   Google Scholar
• Tanaka, Y., Albert, M. L., Hujita, F., Nonaka, C., & Oka, T. (2006). Beta-blocker improves language output in aphasia. Presented at the Annual Meeting of the American Neurological Association, Chicago, IL.
   Google Scholar
• Tanaka, Y., Cahana-Amitay, D., Albert, M., Fujita, K., Nonaka, C., & Miyazaki, M. (2010). Treatment of anxiety in aphasia. Procedia Social and Behavioral Sciences, 6, 252–253. doi:10.1016/j.sbspro.2010.08.061
   Google Scholar
• Tanaka, Y., Miyazaki, M., & Albert, M. L. (1997). Effects of increased cholinergic activity on naming in aphasia. The Lancet, 350(9071), 116–117. doi:10.1016/S0140-6736(05)61820-X
   PubMed Web of Science ®Google Scholar
• Thompson, C. K., Den Ouden, D.-B., Bonakdarpour, B., Garibaldi, K., & Parrish, T. B. (2010). Neural plasticity and treatment-induced recovery of sentence processing in agrammatism. Neuropsychologia, 48(11), 3211–3227. doi:10.1016/j.neuropsychologia.2010.06.036
   PubMed Web of Science ®Google Scholar
• Thompson, C. K., & Shapiro, L. P. (2007). Complexity in treatment of syntactic deficits. American Journal of Speech-Language Pathology, 16(1), 30–42. doi:10.1044/1058-0360(2007/005
   PubMed Web of Science ®Google Scholar
• Thompson, C. K., Shapiro, L. P., Kiran, S., & Sobecks, J. (2003). The role of syntactic complexity in treatment of sentence deficits in agrammatic aphasia: The complexity account of treatment efficacy (CATE). Journal of Speech, Language, and Hearing Research, 46(3), 591–607.
   PubMed Web of Science ®Google Scholar
• Tsikunov, S. G., & Belokoskova, S. G. (2007). Psychophysiological analysis of the influence of vasopressin on speech in patients with post-stroke aphasia. The Spanish Journal of Psychology, 10(1), 178–188.
   PubMed Web of Science ®Google Scholar
• Walker-Batson, D., Curtis, S., Natarajan, R., Ford, J., Dronkers, N., Salmeron, E., … Unwin, D. H. (2001). A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke, 32(9), 2093–2098. doi:10.1161/hs0901.095720
   PubMed Web of Science ®Google Scholar
• Walker-Batson, D., Unwin, H., Curtis, S., Allen, E., Wood, M., Smith, P., … Greenlee, R. G. (1992). Use of amphetamine in the treatment of aphasia. Restorative Neurology and Neuroscience, 4(1), 47–50. doi:10.3233/RNN-1992-4106
   PubMed Web of Science ®Google Scholar
• Whiting, E., Chenery, H. J., Chalk, J., & Copland, D. A. (2007). Dexamphetamine boosts naming treatment effects in chronic aphasia. Journal of the International Neuropsychological Society: JINS, 13(6), 972–979. doi:10.1017/S1355617707071317
   PubMed Web of Science ®Google Scholar